Navigation Links
Roger Graham Named President of Mylan Specialty
Date:6/24/2013

PITTSBURGH, June 24, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the appointment of Roger Graham as president of Mylan Specialty. Graham will report to Tony Mauro, president of Mylan North America.

Mylan CEO Heather Bresch commented, "Roger's deep brand pharmaceutical industry experience, entrepreneurial mind-set and goal-oriented leadership make him the ideal candidate to lead Mylan Specialty as we continue to expand this important business. We remain very excited about the growth prospects of the Specialty business and are confident that Roger will bring immediate value to our entire North American organization and help accelerate achievement of our ambitions for Mylan Specialty." 

Graham joins Mylan from Advandx, a private developer of in-vitro diagnostic tests in the infectious disease space. He was the company's chief commercial officer and developed its growth strategy for the U.S. and European markets.

Prior to that, Graham spent nearly a decade in executive-level marketing and sales positions at three brand pharmaceutical firms, Auxilium Pharmaceuticals, Adolor Corporation and Yamanouchi Pharma America, where he established, rebuilt and/or expanded U.S. commercial operations.

Earlier, Graham worked at Ortho McNeil, a division of Johnson & Johnson (J&J), where he was vice president of the company's $2 billion anti-infective, analgesia and urology franchise, and its 2,300 primary care and hospital sales and marketing associates. Graham also built Ortho McNeil's $500 million neuroscience and metabolic franchise via the launch and life cycle development of Topamax®.

Graham previously served as director of Marketing for Roche's CNS, pain and dermatology franchises. He began his career with Schering-Plough and, over nearly a decade, took on positions of increasing responsibility in the company's allergy, respiratory and oncology sales and marketing organizations.

Graham has a bachelor's degree in business administration from The University of Kansas and an MBA from Seton Hall University.

This press release includes statements that constitute "forward-looking statements," including with regard to the company's future growth and performance. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the impacts of competition; changes in economic and financial conditions of the company's business; the ability to attract and retain key personnel; uncertainties and matters beyond the control of management; and the other risks detailed in the company's filings with the Securities and Exchange Commission. The company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com


'/>"/>
SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Roger bridges the understanding gap for students with hearing loss
2. Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
3. $4 Co-pay on Kroger Premium Blood Glucose Test Strips
4. Kroger Announces Merger with Axium Pharmacy
5. Flu Shots Available Now at Krogers Family of Pharmacies and The Little Clinic
6. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
7. Graham Cooper Appointed Chief Financial Officer of Receptos
8. Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
9. Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
10. Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS
11. Baby Eva Named After Pioneering IVF Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... COUNTY, Calif. , May 3, 2016  While you may be familiar with watching a ... resolution , also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a ... manufacturer of innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... Calif. , May 3, 2016  Specialty ... teaching tool that shows how a cleanroom works. ... classroom discussions about science and technology. ... said, "As a technology company, SSF enthusiastically supports ... to help educators foster the next generation of ...
(Date:5/2/2016)... , May 2, 2016 Kalorama Information ... (Electronic Medical Records) market in a recent white paper.  ... switches, Increased physician usage, a growing market are among ... noted in Kalorama,s report EMR 2016: The ... marks Kalorama,s seventh complete study of the EMR industry, ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... 2016 , ... Washington Wellness Center today announced its tenth anniversary of providing ... started out as an idea to provide a holistic approach to wellness has now ... by Dr. David Swanekamp, Chiropractic Physician , the wellness center offers a complete ...
(Date:5/4/2016)... ... 2016 , ... Dr. Elyson and Dr. Assili, dentist in Northridge , ... tooth removal, a common dental procedure, is performed for many adolescents and young adults ... in risks of complications. By providing wisdom tooth removal surgery at their office, Dr. ...
(Date:5/4/2016)... ... May 04, 2016 , ... Recognizing that lifestyle medicine is essential to health ... have tapped David Katz, MD, MPH, president of the American College of Lifestyle Medicine, ... medicine is especially gratifying,” said Katz. “There is so much opportunity to add years ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... the pharmacy industry, today announced that it was chosen as the Pharmaceutical News ... Industry Awards . The awards acknowledge the hard work and dedication of community ...
(Date:5/4/2016)... ... May 04, 2016 , ... Advanced Spine & Sport Medical ... its patients’ health, is hosting a free seminar on stem cell injections. The seminar ... Advanced Spine & Sport, 4601 Telephone Road, Suite 110, Ventura, CA. There are only ...
Breaking Medicine News(10 mins):